We have examined the effects of direct intratracheal instillation of purified eosinophil granule proteins on pulmonary function and airway responsiveness in primates. The results of this study show for the first time that installation of major basic protein (MBP) directly into the trachea of primates results in a significant and dose-related increase in airway responsiveness to inhaled methacholine. Furthermore, MBP and eosinophil peroxidase (EPO) induce a transient bronchoconstriction immediately after instillation that resolves by 1 h postinstillation. In constrast, instillation of other eosinophil granule proteins had no effect on airway responsiveness or pulmonary function. These data indicate a direct role of the eosinophil in the pathogenesis of airway hyperresponsiveness.
Introduction
Nonspecific airway hyperresponsiveness is defined as an extreme bronchial sensitivity to pharmacological or physiological stimuli and is a characteristic feature of bronchial asthma (1) . Whereas the underlying mechanism(s) in the pathogenesis of acute and chronic airway hyperresponsiveness are largely unknown, many recent studies have suggested an active role of nonresident proinflammatory cells that infiltrate specific localities of the lung and which are capable of releasing potent preformed and/or newly generated proinflammatory mediators (2) (3) (4) . In particular, an association between blood and lung eosinophilia and bronchial asthma has been firmly established, bronchial hyperresponsiveness has been lacking. The most suggestive studies to date have shown that the degree ofperipheral blood eosinophilia inversely correlates with the severity of asthma (5) .
We have previously demonstrated that repeated antigen inhalation results in the development of persistent airway hyperresponsiveness (6) . This chronic airway hyperresponsiveness correlated with both increased numbers of airway eosinophils and the amount of MBP recovered in bronchoalveolar lavage fluid in a primate model of extrinsic asthma. As a result of these findings we reasoned that toxic cationic eosinophil granule proteins, including the major basic protein (MBP).' eosinophil cationic protein (ECP), eosinophil peroxidase (EPO), and eosinophil-derived neurotoxin (EDN), might be primary mediators capable of inducing airway hyperresponsiveness and thereby alter lung function. In this report we show for the first time, that eosinophil-granule MBP can induce transient changes in lung function and airway responsiveness in vivo providing direct evidence for an eosinophil contribution to pulmonary dysfunction in primates. Both MBP and EPO caused an acute, transient decrease in airway caliber occurring immediately after instillation which was resolved by 60 min. However, only MBP induced a dose-related increase in airway responsiveness to inhaled methacholine 2 h postinstillation which returned to baseline values (preinstillation) by 4 h. ECP and EDN had no effect on airway responsiveness or pulmonary function. These studies strongly suggest that MBP, a component of the crystalline core of the eosinophil granule, may be involved in the pathogenesis of acute airway hyperresponsiveness and altered lung function seen in asthma and other allergic inflammatory lung diseases.
Methods
Animals. The animals used in this study were wild-caught adult male cynomolgus monkeys (Macaca fascicularis) weighing 3. Inc., Naperville, IL), intubated with a cuffed endotracheal tube and seated in an upright position in a specially designed support chair. Ketamine (4 mg/kg, i.m.) was used as supplemental anesthesia as needed. Baseline R. was monitored for 15 min followed by methacholine dose response determinations. After completion ofthe methacholine dose response each animal received an intratracheal injection of either vehicle or purified eosinophil-derived granule protein. Rr, was then monitored for 1 h postinstillation, after which the animals were allowed to recover from anesthesia. At 2 and again at 4 h postinstillation each animal was anesthetized (ketamine/xylazine) and intubated, and methacholine dose response determinations were carried out. The study design was a modified cross-over in which each of the five animals received vehicle instillations and each ofthe purified granule proteins in random order during separate experiments. Animals were rested 3 to 4 wk between studies.
Intratracheal protein instillations. Eosinophil cytoplasmic granule proteins were isolated and purified as previously described (7). Granule proteins were stored at -701C until just before intratracheal instillation. Proteins were diluted in PBS (pH 7.0) to appropriate concentrations (total volume instilled was 5 ml in each case) immediate before instillation. Proteins were slowly infused into the trachea via a 20-cmlong piece of PE 240 tubing attached to a 5-ml syringe.
Rrs measurements. Respiratory system impedance (Zn,) was measured by discrete frequency (4-40 Hz in eight equal logarithmic steps) sinusoidal forced oscillations superimposed on tidal breathing as previously described by Wegner and associates (8) 
Results
The acute effects of purified granule proteins on pulmonary function were evaluated and the results are illustrated in Fig. 1 . MBP (1 mg) and EPO (2 mg) induced consistent increases in R~, occurring immediately after administration, usually peaking at 10 min, that were resolved to preinstillation levels by 60 min. ECP instillation caused an increase in two of the five animals studied while instillation of EDN had no effect on R,. The effects of direct intratracheal instillation of purified eosinophil-derived granule proteins on airway responsiveness to inhaled methacholine were assessed and compared to the effect of column buffer instillation in a randomized cross-over study design in five animals. MBP instillation resulted in a dose-related decrease in the PC 100 values for each animal indicating an increase in airway sensitivity to inhaled methacholine (Table I ). The mean change in log PC100 values for 500 and 1,000 ,g MBP were -0.39±0.13 and -1.02±0.36, respectively.
MBP-induced increases in airway responsiveness were indicated by a parallel shift to the left in the cumulative methacholine dose response curves (Fig. 2) . Airway responsiveness returned to baseline (preinstillation) levels 4 h post-MBP instillation. In contrast, instillation of ECP, EPO, EPO + H202 + KI, EDN, and column buffer (obtained during protein purification) in the same group of animals did not significantly increase airway responsiveness.
Discussion
Asthma is characterized by a large infiltration ofeosinophils in the bronchial mucosa (9) . Studies have shown that eosinophil counts and MBP levels are elevated in BAL fluid obtained from asthmatics as compared to nonasthmatics and correlate with the severity ofasthma (10). Furthermore, MBP has been shown to be localized on damaged epithelial surfaces and in mucus plugs in the airways of patients who died from status asthmaticus (1 1). One hypothesis ofthe mechanism ofaction ofeosinophil involvement in bronchial hyperresponsiveness has therefore focused on the cytotoxic effects of the eosinophil-derived granule proteins (reviewed in reference 1 1). Data supporting this hypothesis come from studies demonstrating that each of the granule proteins, with the exception of EDN, are toxic to guinea pig tracheal epithelium resulting in exfoliation and ciliostasis (12, 13) . Exfoliation of epithelial cells may lead to hyperresponsive airways as many studies have demonstrated increased responsiveness of airway smooth muscle to constrictor mediators after the epithelium has been removed in vitro (1 1). However, more recent studies have shown that MBP, at subcytotoxic concentrations, can increase the responsiveness of smooth muscle, indicating that changes in responsiveness can occur with an intact epithelium (14) . Furthermore, data from other studies have indicated that MBP-induced increases in smooth muscle responsiveness may require an intact epithelium and suggest the release of an epithelial-derived constricting factor(s) and/or the inhibition of a relaxing factor(s) (15, 16) . In previous studies, we demonstrated that repeated antigen inhalation caused chronic airway eosinophilia and airway hyperresponsiveness in primates (6, 17 
